Tuesday, December 29, 2020

Zydus Cadila receives DCGI nod for NAFLD drug in India

Zydus Cadila receives DCGI nod for NAFLD drug in India The Drug Controller General of India (DCGI) has approved the new drug application (NDA) for Saroglitazar Mg for the treatment of non-alcoholic fatty liver disease (NAFLD) in India, Zydus Cadila said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/2MjQTfu
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Network18 Q4 loss at Rs 29.61 crore, revenue up 9.7% to Rs 615.78 cr

Network18 Media & Investments reported a consolidated net loss of Rs 29.61 crore for the March quarter, despite a 9.7% rise in operation...